Abstract
We discovered a new chemical class of antiproliferative agents, 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides. SAR-guided optimization of the two distinct terminal fragments yielded a compound with 120 nM potency in an antiproliferative assay. Biological activity profile studies (COMPARE analysis) demonstrated that 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides act as tubulin inhibitors, and this conclusion was confirmed via biochemical assays with pure tubulin and demonstration of increased numbers of mitotic cells following treatment of a leukemia cell line.
Keywords:
Chemotherapeutic agents; DU-145; Prostate cancer; Rational single-molecule polypharmacy; Screening; Tubulin inhibitor.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Dose-Response Relationship, Drug
-
Drug Discovery
-
Drug Screening Assays, Antitumor
-
Humans
-
Molecular Structure
-
Oxadiazoles / chemical synthesis
-
Oxadiazoles / chemistry
-
Oxadiazoles / pharmacology*
-
Piperidines / chemical synthesis
-
Piperidines / chemistry
-
Piperidines / pharmacology*
-
Structure-Activity Relationship
-
Tubulin / metabolism*
-
Tubulin Modulators / chemical synthesis
-
Tubulin Modulators / chemistry
-
Tubulin Modulators / pharmacology*
Substances
-
4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamide
-
Antineoplastic Agents
-
Oxadiazoles
-
Piperidines
-
Tubulin
-
Tubulin Modulators